US Edition
AB Science Has Received Approval From Several European Countries to Initiate the Confirmatory Phase 3 Study of Masitinib in ALS
6 Articles
6 Articles
AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS THIS APPROVAL FOLLOWS PROTOCOL VALIDATION BY THE EMA AND FDA AUTHORIZATION Paris, July 24, 2025, 8am CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the confirmatory Phase 3 study with masitinib in amyotrophic lateral sclerosis (ALS), study AB23005, has been …
The Official State Gazette (BOE) published on Wednesday the royal decree regulating the direct grant of a grant of ten million euros to the National Consortium of ELA Entities (ConELA), which aims to improve the quality of life of people affected by amyotrophic lateral sclerosis (ALS) in advanced phases of the disease.
The Council of Ministers has given the green light this week to a Royal Decree that authorizes the direct granting of a subsidy of 10 million euros to the National Consortium of ALS Entities (ConELA). The fundamental purpose of this initiative is to improve the quality of life of people affected by amyotrophic lateral sclerosis (ALS) who are […] The entry The central government approves direct aid for 24-hour professional care for people affecte…
The Council of Ministers has approved the Royal Decree that regulates the direct granting of a grant of 10 million euros to the National Consortium of ELA Entities (ConELA) to improve the quality of life of people affected by Amyotrophic Lateral Sclerosis (ELA) in advanced phases. As the Ministry of Health explained at the time, it is a complementary measure to the implementation of Law 3/2024 of 30 October. The Royal Decree establishes that Con…
The Council of Ministers approved on Tuesday the Royal Decree that regulates the shock plan of 10 million euros to grant direct aid to people affected by the commonwealth who need social and health care 24 hours a day. The subsidy is addressed nominally to the Spanish Confederation of ELA Entities (ConELA), which will be the one that channels the aid to the applicants, as announced at the beginning of June by the Minister of Health, Mónica Garcí…
On Tuesday, the Council of Ministers approved a grant of €10 million to support people with ALA who are in advanced stages of the disease and who need permanent care for 24 hours, while the ELA law is in place.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
